The study reported that while ADSC infusion appeared safe, there were no significant differences in total length of hospital stay, ICU‐free days, and ventilator‐free days or in serum ARDS biomarkers (SP‐D, IL‐6, IL‐8) between treatment arms. Here, CXCL8 is linked to acute respiratory distress syndrome.